# Processed Funding Opportunities

**Processing Date**: 2025-07-14 11:57:37  
**Total Opportunities**: 82

## Opportunity List

1. Photonic Crystal Surface-Emitting Lasers (PCSEL) for Advanced Laser Systems (ID: A254-047, Agency: DOD)
2. Underwater Sensing in Surf Zone Environments (ID: A254-046, Agency: DOD)
3. Low-Cost, Expendable, Launch-Agnostic Space Separation System (ID: SF254-01006, Agency: DOD)
4. Photonic Crystal Surface-Emitting Lasers (PCSEL) for Advanced Laser Systems (ID: A25D-020, Agency: DOD)
5. Autonomous Modular Material Handling Equipment for Space Logistics Operations (ID: SF254-D1004, Agency: DOD)
6. Autonomous Space Cargo Network (ASCN): AI-Driven Logistics Automation and Digital Twin Integration for Space Mobility (ID: SF254-01001, Agency: DOD)
7. Project ASTROPAC: Intelligent Cargo Configuration and Deployment Planning for Enhanced Readiness (ID: SF254-D1001, Agency: DOD)
8. Affordable Thermal Protection Solution (ARMREST) (ID: SF254-01005, Agency: DOD)
9. Real-Time Detection and Tracking of High-Velocity Atmospheric Transits (ID: SF254-D1006, Agency: DOD)
10. Underwater Sensing in Surf Zone Environments (ID: A25D-019, Agency: DOD)
11. Project AXIS 54: AI-Enabled Framework for Space Sustainment Technology Prioritization (ID: SF254-01003, Agency: DOD)
12. Project KARMEN: Rapid-Turnaround Spacelift Cargo Test Platform for Empirical Qualification (ID: SF254-D1002, Agency: DOD)
13. Project SpaceKnight: Interactive AI Simulation for USSF Space Sustainment and Contested Logistics Wargaming (ID: SF254-01002, Agency: DOD)
14. Quantum for Space Logistics Demand Planning & Optimization (ID: SF254-01004, Agency: DOD)
15. Virtual Space Cargo Deployment Function for AI-Driven Logistics Planning and Simulation (ID: SF254-D1003, Agency: DOD)
16. Phase I Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need (ID: AFX25E-PTCSO, Agency: DOD)
17. Affordable Release Mechanism (ARM) (ID: SF254-D1005, Agency: DOD)
18. Phase I Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need (ID: AFX255-PCSO1, Agency: DOD)
19. Phase I Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Space Force Stakeholder Need (ID: AFX25E-PTCSO2, Agency: DOD)
20. Phase I Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Space Force Stakeholder Need (ID: AFX255-PCSO2, Agency: DOD)
21. Multi-Fuel Platoon Power Generator (ID: A254-040, Agency: DOD)
22. Additive Manufacturing for Circuitry (ID: A254-043, Agency: DOD)
23. Faraday optical isolator on a photonic integrated laser circuit (ID: O254-009, Agency: DOD)
24. Innovative Interceptor Seekers for Missile Defense in the Space Domain (ID: MDA254-D005, Agency: DOD)
25. Photonic Integrated NV Center in Diamond Vector Magnetometers (ID: O254-007, Agency: DOD)
26. Integrated low noise laser for Barium ion qubits (ID: O254-D08, Agency: DOD)
27. PEO SOF Warrior - Secure and Protect Infrastructure through Cyber-threat Emulation (SPICE) Open Topic (ID: SOCOM254-P0005, Agency: DOD)
28. PEO SOF Warrior - Visual Augmentation Systems (VAS) Open Topic (ID: SOCOM254-P006, Agency: DOD)
29. Predict, Optimize, Recommend, and Track for Adaptive Logistics (PORTAL)â€‹ (ID: A254-045, Agency: DOD)
30. Cognitive Mapping for Counter-WMD Operations (ID: DTRA254-002, Agency: DOD)
31. Space-Based Firing Solutions (ID: MDA254-D003, Agency: DOD)
32. Lightweight Space Based Propulsion Technology for High Acceleration (ID: MDA254-D004, Agency: DOD)
33. Additive Manufacturing for Circuitry (ID: A25D-018, Agency: DOD)
34. Mechanics and Control of Autonomous Legged Robotic Systems in Mud (ID: A254-042, Agency: DOD)
35. Long-Range Joint Precision Airdrop System (LR-JPADS) (ID: A254-044, Agency: DOD)
36. VCSELs for Quantum Sensors (ID: O254-D04, Agency: DOD)
37. Multi-channel amplification on chip for scalable quantum & DE applications (ID: O254-D05, Agency: DOD)
38. Integration of Wave Relay API Features into the Thales InterSense IS-1500 Visual Inertial Tracking Software) (ID: DTRA254-004, Agency: DOD)
39. Multi-Fuel Platoon Power Generator (ID: A25D-015, Agency: DOD)
40. Low Cost Interceptors for Missile Defense (ID: MDA254-D006, Agency: DOD)
41. Mechanics and Control of Autonomous Legged Robotic Systems in Mud (ID: A25D-017, Agency: DOD)
42. Mode-Locked Lasers on Chip toward Frequency Combs and Quantum Applications (ID: O254-D06, Agency: DOD)
43. Blast Injury Simulation in Armored Vehicles Affected by Blast Pressure, Shaped Charge, or Dense Inert Projectile Weapons (ID: DTRA254-001, Agency: DOD)
44. Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers (ID: 2, Agency: HHS)
45. Droppable Chemical Warfare Agent Sensor (ID: DTRA254-003, Agency: DOD)
46. Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. (ID: 1, Agency: HHS)
47. Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. (ID: 1, Agency: HHS)
48. Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers. (ID: 2, Agency: HHS)
49. NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (ID: RFA-HL-26-015, Agency: HHS)
50. NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (ID: RFA-HL-26-014, Agency: HHS)
51. Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (ID: PAR-24-294, Agency: HHS)
52. NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) (ID: PAR-25-133, Agency: HHS)
53. Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) (ID: PAR-24-133, Agency: HHS)
54. Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) (ID: PAR-24-132, Agency: HHS)
55. Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) (ID: PAR-24-134, Agency: HHS)
56. PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) (ID: PA-24-247, Agency: HHS)
57. NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) (ID: PAR-24-222, Agency: HHS)
58. Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) (ID: PAR-24-131, Agency: HHS)
59. NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) (ID: PAR-24-221, Agency: HHS)
60. PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (ID: PA-24-245, Agency: HHS)
61. PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) (ID: PA-24-246, Agency: HHS)
62. PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) (ID: PA-24-248, Agency: HHS)
63. Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) (ID: RFA-MD-24-006, Agency: HHS)
64. Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) (ID: RFA-MD-24-007, Agency: HHS)
65. NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) (ID: PAR-24-099, Agency: HHS)
66. Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (ID: PAR-24-098, Agency: HHS)
67. Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (ID: PAR-24-096, Agency: HHS)
68. Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) (ID: RFA-DA-25-047, Agency: HHS)
69. Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) (ID: RFA-DA-25-048, Agency: HHS)
70. Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed) (ID: RFA-TR-23-018, Agency: HHS)
71. Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed) (ID: RFA-TR-23-017, Agency: HHS)
72. Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (ID: PAR-24-063, Agency: HHS)
73. NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) (ID: PAR-23-311, Agency: HHS)
74. NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) (ID: PAR-24-044, Agency: HHS)
75. NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required) (ID: PAR-24-066, Agency: HHS)
76. Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) (ID: PAR-23-213, Agency: HHS)
77. SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (ID: PAR-23-220, Agency: HHS)
78. SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (ID: PAR-23-219, Agency: HHS)
79. HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) (ID: PAR-23-069, Agency: HHS)
80. Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) (ID: PAS-22-197, Agency: HHS)
81. Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) (ID: PAS-22-196, Agency: HHS)
82. Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) (ID: PAR-23-032, Agency: HHS)

## Summary by Source

- **DOD**: 44 opportunities
- **HHS**: 38 opportunities

---
*Generated by Comprehensive Funding Analysis System*